GlassScriptPhysician profile
Seth M Wilson
NPI 1518490754
$7,151.09
in general payments reported to CMS, 2019-2025
44 companies · $2,083 in 2025
The $2,083 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $218 · 2021: $619 · 2022: $1,049 · 2023: $1,686 · 2024: $1,497 · 2025: $2,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,265.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $748.44 | 2021-2025 | |
| Abbvie INC. | $681.71 | 2021-2025 | Vraylar, Ubrelvy, Synthroid |
| Lilly USA, LLC | $588.42 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $498.29 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $495.94 | 2020-2025 | Verquvo, Belsomra, Welireg |
| Amgen INC. | $441.94 | 2020-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $362.07 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $356.23 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $320.50 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $252.07 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $247.50 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $221.36 | 2022-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $186.71 | 2020-2022 | |
| Phathom Pharmaceuticals, INC. | $179.78 | 2024-2025 | Voquezna |
| Astellas Pharma US INC | $178.56 | 2023-2025 | Veozah, Myrbetriq |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.